{
    "clinical_study": {
        "@rank": "122787", 
        "arm_group": {
            "arm_group_label": "NuCel with Autograft", 
            "arm_group_type": "Experimental", 
            "description": "NuCel will be used with local autograft during surgical treatment of one, two or three level degenerative disease of the lumbar spine"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether NuCel is effective in promoting spinal\n      fusion in degenerative disease of the lumbar spine."
        }, 
        "brief_title": "Efficacy Study of NuCel\u00ae in Patients Undergoing Fusion of the Lumbar Spine", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Intervertebral Disc Disease", 
            "Intervertebral Disc Degeneration", 
            "Spondylosis", 
            "Spondylolisthesis", 
            "Spinal Stenosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Spinal Stenosis", 
                "Spondylolisthesis", 
                "Spondylosis", 
                "Intervertebral Disk Displacement", 
                "Intervertebral Disk Degeneration"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is a prospective, single center clinical trial to establish the efficacy of NuCel,\n      a minimally manipulated allograft tissue, for use in lumbar interbody and intertransverse\n      fusion procedures. Subjects will undergo standard interbody fusion surgery as per the signed\n      informed consent with NuCel and autograft bone. Patients will be evaluated postoperatively\n      at 6 weeks, 3 months, 6 months, 1 year, and 2 years (if required)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must be diagnosed with degenerative disease of lumbar spine\n\n        Exclusion Criteria:\n\n          -  Back pain due to injury\n\n          -  Back pain that is caused by infection, cancer, lesions(growths) or bone disease such\n             as osteoporosis\n\n          -  Any terminal (will not recover from the disease) or autoimmune disease including but\n             not limited to HIV infection, or rheumatoid arthritis\n\n          -  Any other medical condition that might affect normal healing\n\n          -  Less than 21 years of age\n\n          -  More than three levels of fusion needed\n\n          -  Recent history (within past 6 months) of any chemical or alcohol dependence\n\n          -  Morbid obesity (Body Mass Index of more than 40)\n\n          -  Currently a prisoner\n\n          -  Currently experiencing a major mental illness\n\n          -  Pregnancy at the time of enrollment\n\n          -  Previously diagnosed with diseases of the bone such as osteoporosis, osteopenia or\n             osteomalacia (softening of the bones). Patients with any of the risk factors for\n             osteoporosis may have DEXA scans performed prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023372", 
            "org_study_id": "RD2013-11-07"
        }, 
        "intervention": {
            "arm_group_label": "NuCel with Autograft", 
            "description": "NuCel is a minimally manipulated allograft product derived from amniotic membrane along with cells from amniotic fluid.  Local autograft is bone that comes from the patient's own vertebrae and surrounding bony structures.", 
            "intervention_name": "NuCel with Autograft", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "NuCel", 
            "Lumbar Spine", 
            "Degenerative Disease", 
            "Efficacy", 
            "Fusion"
        ], 
        "lastchanged_date": "December 27, 2013", 
        "location": {
            "contact": {
                "email": "peggy.boltes@cnsa.com", 
                "last_name": "Domagoj Coric, MD", 
                "phone": "704-376-1605"
            }, 
            "facility": {
                "address": {
                    "city": "Charlotte", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "28204"
                }, 
                "name": "Carolina NeuroSurgery and Spine"
            }, 
            "investigator": {
                "last_name": "Dom Coric, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "NuTech NuCel\u00ae: A Prospective, Efficacy Study of NuCel\u00ae in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Lumbar Spine.", 
        "overall_official": {
            "affiliation": "Carolina Neurosurgery & Spine Associates", 
            "last_name": "Domagoj Coric, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "CT scan will be used to evaluate fusion of one, two, or three levels", 
            "measure": "Spinal Fusion", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023372"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline pain using Visual Analogue Scale (VAS)", 
                "safety_issue": "No", 
                "time_frame": "6 weeks, 3 months, 6 months, and 12 months"
            }, 
            {
                "measure": "Change from baseline Oswestry Disability Index (Ver. 2.1)", 
                "safety_issue": "No", 
                "time_frame": "6 weeks, 3 months, 6 months, 12 months"
            }, 
            {
                "measure": "X-ray to compare to baseline preoperative X-ray", 
                "safety_issue": "No", 
                "time_frame": "6 weeks, 3 months, 6 months, 12 months"
            }
        ], 
        "source": "NuCel, LLC", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Carolina Neurosurgery & Spine Associates", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Carolinas Healthcare System", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "NuCel, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}